EP2509534A1 - Implant en écharpe à motifs - Google Patents

Implant en écharpe à motifs

Info

Publication number
EP2509534A1
EP2509534A1 EP10798878A EP10798878A EP2509534A1 EP 2509534 A1 EP2509534 A1 EP 2509534A1 EP 10798878 A EP10798878 A EP 10798878A EP 10798878 A EP10798878 A EP 10798878A EP 2509534 A1 EP2509534 A1 EP 2509534A1
Authority
EP
European Patent Office
Prior art keywords
implant
extension portions
tissue
support portion
anchor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10798878A
Other languages
German (de)
English (en)
Inventor
James R. Mujwid
Jessica L. Roll
Kari A Jagger
Robert C. Grant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
AMS Research LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/953,268 external-priority patent/US9060836B2/en
Application filed by AMS Research LLC filed Critical AMS Research LLC
Publication of EP2509534A1 publication Critical patent/EP2509534A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
    • A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
    • A61F2/0045—Support slings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06066—Needles, e.g. needle tip configurations
    • A61B17/06109—Big needles, either gripped by hand or connectable to a handle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00805—Treatment of female stress urinary incontinence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
    • A61F2002/0068—Implantable repair or support meshes, e.g. hernia meshes having a special mesh pattern
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
    • A61F2002/0072—Delivery tools therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
    • A61F2002/0081—Special surfaces of prostheses, e.g. for improving ingrowth directly machined on the prosthetic surface, e.g. holes, grooves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008—Fixation appliances for connecting prostheses to the body
    • A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes

Definitions

  • the present invention relates generally to surgical methods and apparatus and, more specifically, to surgically implantable sling devices and methods for forming and using the same.
  • Pelvic health for men and women is a medical area of increasing importance, at least in part due to an aging population.
  • Examples of common pelvic ailments include incontinence (e.g. , fecal and urinary), pelvic tissue prolapse (e.g. , female vaginal prolapse), and conditions of the pelvic floor.
  • Urinary incontinence can further be classified as including different types, such as stress urinary incontinence (SUI), urge urinary incontinence, mixed urinary incontinence, among others.
  • Urinary incontinence can be characterized by the loss or diminution in the ability to maintain the urethral sphincter closed as the bladder fills with urine. Male or female SUI generally occurs when the patient is physically stressed.
  • Many strategies have been implemented over the years to provide mesh implants adapted to enhance therapeutic support of the respective pelvic tissues. For instance, sling and other implant devices are known to provide support of the urethra or bladder neck in treating urinary incontinence in patients.
  • the present invention describes sling implants and methods for treating pelvic conditions such as incontinence (various forms such as fecal incontinence, stress urinary incontinence, urge incontinence, mixed incontinence, etc.) and other conditions caused by muscle and ligament weakness.
  • Other uses include providing a support or platform for plastic surgery, hernia repair, and ortho repairs and support, to name a few.
  • Embodiments of the implants can include a tissue support portion, one or more extension portions and one or more anchors. Certain embodiments can be constructed as a unitary sling implant.
  • the implant can be constructed or formed in a generally elongate or rectangular shape, or take on a myriad of other compatible configurations or shapes.
  • the support portion is adapted for positioning and support under tissue or organs, such as the urethra or bladder.
  • the extension portions extend out from the support portion such that the anchors or anchoring features can be deployed for tissue fixation.
  • the implants can be formed of patterned cells by way of a molding, die casting, laser etching, laser cutting, extruding, punching, 3-D printing and the like.
  • a pattern cut or formed implant can be constructed of a polymer material to provide a lattice support structure of repeated cells.
  • embodiments of the present invention are a homogeneous unitary construct.
  • Portions of the implant can be formed into sinusoid or other waveform strut members to control and promote elongation, expansion or contraction along single or multiple axes. As such, controlled and designated stress, tension and compression distribution is promoted across specific or localized areas of the construct. Further, portions of the implant can be coated to provide additional control of expansion, and to protect from or promote tissue in-growth.
  • the implant can be formed such that regions or portions can include anchoring features to facilitate engagement and attachment of the implant to target tissue sites.
  • anchoring to internal tissue, it is also possible to have one or more portions of the implant extend out of an incision or orifice in a patient.
  • anchors without or without extending tines, can be defined, formed or otherwise provided with the implant.
  • the anchors can be integrally formed, cut or otherwise defined with the implant. Portions of the implant or anchors can be adapted to collapse, fold or otherwise deform to some extent to facilitate engagement with an introducer or needle device and/or to facilitate tissue penetration or fixation.
  • the material and cell construct of the sling implant can be configured to promote flexibility while still providing optimal implant strength and tissue support. Further, the stable geometrical and dimensional attributes of the implant provide a flexible device that can be easily positioned and deployed while also avoiding undesirable implant warping or bunching. Such a configuration generally promotes a sling implant adapted to substantially remain in plane during deployment and tissue fixation.
  • the sling implants, or portions thereof, can be adapted to provide desirable adjustability, stress distribution, anchoring, stabilization, variable elongation, and the like.
  • Fig. 1 is a perspective view of a unitary patterned sling implant having generally transverse extending anchoring features in accordance with embodiments of the present invention.
  • Fig. 2 is a top view of the unitary patterned sling implant of Fig. 1.
  • Fig. 3 is a close-up partial view of a portion of the unitary patterned sling implant of Fig. 2.
  • Fig. 4 is a close-up partial view of an anchoring feature, transition zone and extension portion of a unitary patterned sling implant in accordance with embodiments of the present invention.
  • Fig. 5 is a perspective view of a unitary patterned sling implant having generally transverse extending anchoring features in accordance with embodiments of the present invention.
  • Fig. 6 is a top view of the unitary patterned sling implant of Fig. 5.
  • Fig. 7 is a close-up partial view of a portion of the unitary patterned sling implant of Fig. 6.
  • Fig. 8 is a close-up partial view of an anchoring feature, transition zone and extension portion of a unitary patterned sling implant in accordance with embodiments of the present invention.
  • Fig. 9 is a perspective view of a unitary patterned sling implant having planar extending anchoring features in accordance with embodiments of the present invention.
  • Fig. 10 is a top view of the unitary patterned sling implant of Fig. 9.
  • Fig. 11 is a close-up partial view of a portion of the unitary patterned sling implant of Fig. 10.
  • Fig. 12 is a perspective view of a unitary patterned sling implant having planar extending anchoring features in accordance with embodiments of the present invention.
  • Fig. 13 is a top view of the unitary patterned sling implant of Fig. 12.
  • Fig. 14 is a close-up partial view of a portion of the unitary patterned sling implant of Fig. 13.
  • Fig. 15 is a perspective view of a unitary patterned sling implant having planar extending anchoring features in accordance with embodiments of the present invention.
  • Fig. 16 is a top view of the unitary patterned sling implant of Fig. 15.
  • Fig. 17 is a close-up partial view of a portion of the unitary patterned sling implant of Fig. 16.
  • Fig. 18 is a perspective view of a unitary patterned sling implant having planar extending anchoring features in accordance with embodiments of the present invention.
  • Fig. 19 is a top view of the unitary patterned sling implant of Fig. 18.
  • Fig. 20 is a close-up partial view of a portion of the unitary patterned sling implant of Fig. 19.
  • Figs. 21-22 show exemplary sling introduction tools in accordance with embodiments of the present invention.
  • Figs. 23-34 show various patterned cell configurations and spacer elements for sling implants in accordance with embodiments of the present invention.
  • Figs. 35-50 show various tear zones, structures and methods for sling implants in accordance with embodiments of the present invention.
  • the implant 10 can include a support portion 12, one or more extension portions 14 and one or more anchoring features 16.
  • the extension portions 14 include the material construct extending from the support portion 12 to the respective anchoring features 16.
  • Various portions of the implant 10 can be constructed of polymer materials, e.g. , into a molded generally planar structure or cut from a thin generally planar film or sheet material. Examples of acceptable polymer materials available in constructing or forming the implant systems 10 and its components can include polypropylene, polyethylene, fluoropolymers or like biocompatible materials.
  • sling implant 10 various embodiments of the sling implant 10 are shown. Portions of the implant 10, such as the support portion 12 and the extension portions 14, can be formed or patterned by way of a polymer molding process to create a unitary homogeneous non-woven, or non-knitted, device or construct. Other embodiments can be formed from an already unitary homogeneous sheet or film via laser cutting, die cutting, stamping and like procedures.
  • the support portion 12 can be configured and shaped for positioning under and support of the urethra or bladder (which includes any location of the bladder, urethra, bladder neck, mid-urethra, or proximal end of the urethra), with the extension portions 14 extendable out to proximate muscle, ligament or other tissue for anchoring.
  • the implant also can be used to support pelvic tissue such as the vaginal tissue, tissue of the perineum, coccygeus, levator ani, levator hiatus, and rectum.
  • the implant width, at any portion can be approximately 5 mm to 15 mm, and the length from end to end can be approximately 6 cm to 15 cm.
  • Repeated cells or patterns in the implant 10 generally form a lattice structure. Portions of the implant 10 can be cut into sinusoid, or other waveform or undulating struts 15 patterns to control elongation or compression along single or multiple axes, to define a desirable pattern density with overall reduced surface area, and to control the distribution and shaping from applied loads.
  • the ability to mold, form or cut the struts 15 in a nearly endless array of sinusoidal or like configurations provides an implant 10 that can better tailor or mimic the anisotropic behaviors of physiological tissue.
  • the film or unitary construct of the implant can have a thickness T of approximately .005 inches to .020 inches, and the struts 15 can have a width W of approximately .005 inches to .012 inches.
  • Other configurations, shapes and sizes for the various portions of the implant 10 can be employed as well to promote and facilitate the deployment, use and support of the implant 10 disclosed herein.
  • the patterned struts 15 define a general pinwheel design including first angular strut lines 20 and second angular strut lines 22 crossing or intersecting at repeating fixed junctions 24 to define cellular voids 26.
  • the thickness, size and separation of the struts 15 can be modified to create an implant 10 with different surface area and cellular density attributes.
  • the struts 15 can have uniform or variable widths or thicknesses, can be tapered, can include apertures, or can include defined shapes and/or patterns, e.g. , sinusoids, squares, elliptical, triangular, elbowed, straight, or other simple or complex shapes and patterns.
  • Unique strut 15 designs and cellular patterns can be included within a single implant 10 to provide different zones, having different stress, load distribution or compression characteristics. Other strut 15 designs and patterns can be employed as well to achieve the functionality described and depicted herein.
  • the dimensional design of the implant struts 15 can be configured to promote targeted strength and flexibility.
  • the material width at the fixed junctions 24 can be measurably greater than the material width W of the struts 15 intermediate the junctions to allow for increased strength at the junctions.
  • Strengthened and widened junctions 24 can handle and absorb greater stress or torque resulting from implant positioning, twisting and general manipulation.
  • thinner strut portions intermediate the junctions 24 promote increased flexibility and controllability of the implant 10 during positioning and device manipulation. This flexibility will also provide an implant 10 adapted to properly conform to unique patient anatomy and lay flat against such anatomy to provide optimal support distribution, tissue in-growth and like characteristics.
  • Other dimensional ranges and proportions are envisioned for embodiments of the struts and strut portions depending on the particular application, strength, flexibility, stress distribution or other performance needs of the implant.
  • a flexible but strong implant 10 is provided, while still maintaining a low surface area, lower inflammatory response, less scarring and increased density.
  • the patterned sling implant 10 also provides benefits over traditional knitted or woven mesh in the area of compression and the reaction to longitudinal extension strain.
  • Traditional knitted or woven mesh implants can tend to compress, narrow, bunch or fold during longitudinal stretching, thereby displaying a positive Poisson affect or ratio.
  • the sinusoidal pinwheel cell and strut configurations of the patterned implants 10 of embodiments of the present invention can display a Negative Poisson affect or ratio.
  • the implant 10 is loaded or stretched (e.g.
  • the strut and cell structures resist compression and can measurably expand to provide a stable and generally planar surface area for tissue or organ support.
  • the combination of the struts and fixed junctions facilitate this Negative Poisson affect.
  • the support portion 12 can take on physical and design characteristics to promote tissue or organ support, and to reduce or eliminate undesirable erosion.
  • the support portion 12 can be measurably wider than the extension portions 14 in certain embodiments.
  • Relatively narrow extension portions 14 can promote flexibility and positioning of the implant 10 within the patient, without jeopardizing the size and effectiveness of the support portion 12.
  • the support portion 12 can include one or more apertures 13 adapted to reduce tissue erosion, and to promote tissue in-growth, flexibility and tissue support.
  • Embodiments of the implant 10 can include one or more transition portions or zones 30, as shown particularly in Figs. 4 and 8.
  • the zones 30 provide a material transition between the cellular construct of the extension portions 14 and anchoring or like features of the implant 10, e.g. , anchors, eyelets, etc.
  • the transition zones 30 can take on various sizes, shapes and designs to provide increased strength and stress absorption/distribution for portions of the implant 10 being pulled, pushed and twisted during deployment and positioning of the implant 10.
  • Embodiments of the zones 30 can include arcuate or linear members 30a extending out from or into the extension portions 14 and the anchoring portions 16.
  • the members can be tapered into or away from the extension portion 14 or anchoring portion 16 to facilitate stress and tension distribution such that the struts 15 and cell structures of the extension portion 14, or support portion 12, are protected from tearing, ripping or other material breaches.
  • Such a design further provides beneficial flexibility and manipulation characteristics during deployment.
  • Figs. 9-20, and 23-34 demonstrate implants 10 and/or implant cell portions having various linear, angled and shaped struts 15 to define unique patterned cell configurations.
  • the thickness, size, shape and separation of the struts 15 can be modified to create an implant 10 with different surface area, void or pore shapes/sizes, and cellular density attributes.
  • the support portion 12 can take on a different pattern or size configuration than the extension portions 14 to facilitate support, reduce erosion and bunching, or to promote like considerations.
  • the strut cell patterns can be separated or symmetrically distributed by way of various spacer elements 15a.
  • implants 10 can be provided in which mechanical characteristics are uniform within the plane of the implant 10 regardless of the direction of an applied stress (e.g. , isotropic).
  • the implant 10 e.g. , support portion 12 or extension portions 14
  • the implant 10 may be configured so that mechanical properties differ substantially along selected axes.
  • the implant 10 can be formed or cut such that certain edges or other portions can include edge features 32, e.g.
  • teeth, tines, tangs, angled portions, wisps, members, strut portions, stabilizers or other like features to provide capture points for materials or tissue that pass proximate the implant, or to serve as a means of assistive tissue anchoring during or after deployment of the implant 10.
  • the shaped or cut cells, or patterns can be configured to optimize or increase tissue in-growth, to promote load bearing along select portions of the implant, and to compensate for stiffness, elongation, tensile strength and warping or bunching resistance.
  • the implant 10 e.g. , portions 12, 14
  • the implant 10 can include a plurality of protuberances or nubs generally extending and lying within the cell structure or strut 15 construct of the implant 10.
  • One or more of the nubs can be included within any, or all, of the defined cell voids 26.
  • the nubs can extend substantially along the same plane as the implant 10, or generally transverse to that plane.
  • the nubs can provide increased load support and contact points while not substantially increasing the surface area of the implant 10.
  • the anchor portions 16 can include first and second end anchors 34, 36 extending out from the implant 10.
  • the anchoring features 16, such as the end anchors 34, 36, can be formed (e.g. , molded), cut or otherwise defined integrally with the unitary implant 10.
  • the anchors 16 can include a distal end 40 adapted to penetrate or otherwise engage tissue within the patient, and one or more extending (e.g. , angled, straight, curved, etc.) tines or barbs 42 to facilitate tissue fixation.
  • the tines 42 can be generally flexible or deformable to allow for compression or collapsibility when a level of force is applied at the top of the tines 42. Once the tissue catches the tip of the tines 42, or force is applied from the underside of the tines 42, the tines 42 expand to fixate to the tissue.
  • the anchor width e.g., tine tip to tip
  • the anchor length e.g. , tip to tail
  • the anchors 16 can further include a barrel or body portion 46, as shown in Figs. 4 and 8.
  • the body portion 46 can include an interior lumen 48 adapted to selectively engage with an insertion or introduction tool (e.g. , insertion needle tip).
  • an insertion or introduction tool e.g. , insertion needle tip
  • the anchors 16 can extend out generally transverse from the plane of the extension portions 14 of the sling implant 10.
  • Such an anchor design is adapted to decrease insertion force while also increasing desirable holding force within the tissue.
  • the anchors 16 can extend out from and generally along the same plane as the extension portions 14 of the sling implant 10.
  • Embodiments of the anchoring features 16, such as those depicted in Figs. 9- 10, can be formed or cut into relatively thin (e.g. , relative to the thickness of the support portion 12 or extension portions 14) anchors 34, 36.
  • the anchors 34, 36 can define two generally mirroring portions 37a, 37b.
  • the portions 37a, 37b can be adapted to fold on each other about a central portion 39 to create a generally 3-D anchor such that a needle or other introducer device is attachable to the anchoring feature 16 (e.g. , at a feature, structure or aperture 39a) at or proximate the central portion 39, or any other portion of the anchoring features 16.
  • anchoring features 16 can include various apertures, slits, lumens, barrels, clips, snaps, structures or regions to facilitate or accommodate connection or selective engagement with a needle or other introducer device.
  • anchoring features 16 can be formed integral with or separately coupled with the implant 10 or extension portions 14.
  • anchors 34, 36 can be rotatably or pivotably affixed to the sling implant 10.
  • implant 10 can include markings or indicia to indicate lines or sections to assist in deployment, positioning and adjustment.
  • scoring, indenting, crushing and like procedures or features can be included along one or more portions of the implant 10 to indicate trimming or sizing lines or zones.
  • punching, die cutting, 3-D printing and other methods and techniques can be used to form or define the implant 10.
  • Portions of the implant 10 can be coated to provide additional control of expansion, and to protect from or promote tissue in-growth.
  • the material surface or surfaces of the implant 10 or cells can be smooth or rough to promote mechanical or tissue in-growth characteristics.
  • the ability to form or cut the support and extension portions 12, 14, or other portions of the implant 10, in a nearly endless array of configurations provides an implant that can better tailor or mimic the anisotropic behaviors of physiological tissue. This also can provide a sling implant 10 having significantly less surface area than traditional mesh implants.
  • These configurations for the patterned sling implant 10 can assist in maintaining the implant in a generally flat or predefined plane or position during deployment, which will in turn make placement easier for the physician and reduce incidence of pain syndromes, erosion, etc.
  • the density of the cell patterns with the embodiments of the implants 10 of the present invention, it is possible to tailor the elongation, load or strength properties of the implant 10 according to specific needs and support requirements.
  • more than one material can be used to construct the implant 10 to further control desired load and stress properties, e.g. , combining different polymers such as polypropylene, PEEK, PET, PTFE, PGA, PLA, etc.
  • Polymers could also be combined with metallic elements to alter strength and elongation profiles of the implant 10. The stronger materials would take up stresses from higher load regions faster, thereby allowing for a method to selectively control performance characteristics of the implant 10.
  • a polymer or metal frame or feature could be provided along the periphery or other select areas of the implant 10 to provide additional strength or rigidity properties.
  • various structures and components of the present invention can be integrally formed into a unitary body via a molding process.
  • an injection molding machine e.g. , Milacron Roboshot S2000i 33B machine
  • a dry resin such as a polypropylene resin
  • the mold device can be heated.
  • the mold vacuum lines can be started and the injection molding cycle initiated.
  • the mold cavities will be filled and the device will be cooled for a period of time.
  • the mold is opened and part ejection will activate with evacuation.
  • the mold can then be closed and the cycle repeated for additional injection molded implants.
  • Other known molding processes and systems can be employed with the present invention as well.
  • implant 10 can be formed or cut along a precise cutting tool path (e.g. , using the DPSS 266 laser system), to cut the implant 10 and strut 15 features and designs in an already unitary film or sheet of polymer material.
  • the implant features and portions can be stamped into such a unitary film or sheet material.
  • various implant 10 portions and methods of forming such portions are disclosed to facilitate preferential or targeted tear zones 50.
  • the implant 10 can, therefore, include portions that can be removed by the physician or other users according to the patient' s unique anatomical makeup, surgical requirements, and the like.
  • a direct extrusion or 3-D printing method is employed such that a polymer is extruded or printed onto a surface to create a structure or construct of the implant 10 to form the tear zones 50.
  • These tear zones 50 allow for a structure that can be pulled apart in a controlled manner. This is useful in applications where a portion of the structure or implant 10 is not needed and can be removed with or without the need for a cutting instrument. As such, damage that might occur to the structure or portion of the implant 10 by using a cutting instrument can be avoided if so desired.
  • the direct extrusion or 3D printing method creates the structure by pushing a thermoplastic above the melting point and out of a small orifice or nozzle device 54, as shown in Figs. 46-48.
  • the extruded hot plastic is then "drawn" or otherwise provided on a surface of the implant (e.g. , strut, film, etc.) to create a tear structure, where the extrudant forms a thin single tear strut, structure or feature 52 in the design or at a portion of the implant 10.
  • the bond strength can be controlled to create zones for predefined tearing. These zones 50 or tear structures/struts 52 can be increased in size or thickness when more force is required to facilitate tearing or separation, or can be formed relatively thin when less separation or tearing force is desired.
  • certain methods for controlling bond strength of the zones 50 can include controlling the amount of physical overlap PO between the new extrudant N and the previously laid down material P, and controlling the time the heated extruder nozzle dwells on the previously laid down material P to cause significant re-melting and joining flow of the material P with the new extrudent N.
  • bond strength can be controlled by varying the number of individual extrudant strands or bonds that make up a strut (e.g. , Figs. 41-45, 49-50), and by bridging the new extrudant N to the previously laid down material P.
  • Bridging can occur when the nozzle device 54 presses into the previously laid down material P to re-melt and flow a small portion of it into a thin bridge of material that bonds to the new extrudant N, as shown in Figs. 47-50.
  • Other known extrusion, molding, printing or like formation methods and techniques are also envisioned for use in defining predefined tear zones 50 in portions of the implant 10.
  • the implants 10 described herein can be implanted into a patient by use of various different types of surgical tools, including insertion tools, which generally are tools useful to engage and place a tissue anchor and elongate incontinence sling.
  • insertion tools which generally are tools useful to engage and place a tissue anchor and elongate incontinence sling.
  • Various types of insertion tools are known, including those in the previously- incorporated references, and these types of tools and modifications thereof can be used according to the present description to install the sling implant 10.
  • Each tool 60 can include a handle 62, needle 64 and engaging distal tip 66.
  • the handle 62 can include an actuation mechanism 63 in operative communication with the distal tip 66 and adapted to selectively control engagement and/or disengagement of the distal tip 66 with portions of the implant 10 (e.g. , anchors 16).
  • the needle 64 can be helical, straight, or curved, to name a few options.
  • a portion of the needle 64, such as the needle tip 66, can include one or more barb guards adapted to receive or abut against the one or more tines 42 of the anchors 16 to protect from undesirable tissue contact or penetration during initial deployment and positioning of the implant 10 (e.g. , prior to target tissue fixation).
  • Embodiments of the present invention can be implanted in a patient to treat incontinence, such as urinary incontinence.
  • the tool 60 e.g. , needle 64
  • the incision may be, for example, a vaginal incision (for female anatomy), a perineal incision (for male anatomy), or an incision in the rectal or buttock region, inner thigh or groin, pubic region, etc.
  • the needle tip 66 can be connected to a first of the anchor features 16 (e.g. , anchor 34) and placed at a desired location for fixation of the anchoring feature 16 to target tissue, such as at an obturator foramen.
  • the other of the anchor features 16 (e.g. , anchor 36) can be bilaterally deployed and fixated (e.g. , to the obturator foramen) on the other side of the supported organ.
  • the support portion 12 can then be adjusted and tensioned relative to the supported organ/tissue (e.g. , urethra or bladder) as needed.
  • the implants 10, their various components, structures, features, materials and methods may have a number of suitable configurations as shown and described in the previously-incorporated references.
  • Various methods and tools for introducing, deploying, anchoring and manipulating implants to treat incontinence e.g. , male and female
  • incontinence e.g. , male and female
  • All patents, patent applications, and publications cited herein are hereby incorporated by reference in their entirety as if individually incorporated, and include those references incorporated within the identified patents, patent applications and publications.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Selon les modes de réalisation, la présente invention porte sur des implants pelviens allongés destinés à traiter des états pelviens, tels qu'une incontinence. Les implants (10) comprennent une partie support en tissu (12), une ou plusieurs parties extension (14) et un ou plusieurs ancrages (16). L'implant est réalisé comme une écharpe unitaire non tissée. L'implant peut être réalisé ou formé selon une forme en général allongée afin de fournir une structure de support de réseau de cellules répétitives, défini par une pluralité d'éléments d'entretoise (15) reliés à une pluralité de jonctions fixes et s'étendant à partir de celles-ci.
EP10798878A 2009-12-09 2010-12-09 Implant en écharpe à motifs Withdrawn EP2509534A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26788809P 2009-12-09 2009-12-09
US29138509P 2009-12-31 2009-12-31
US12/953,268 US9060836B2 (en) 2009-11-23 2010-11-23 Patterned implant and method
PCT/US2010/059739 WO2011072148A1 (fr) 2009-12-09 2010-12-09 Implant en écharpe à motifs

Publications (1)

Publication Number Publication Date
EP2509534A1 true EP2509534A1 (fr) 2012-10-17

Family

ID=46208930

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10798878A Withdrawn EP2509534A1 (fr) 2009-12-09 2010-12-09 Implant en écharpe à motifs

Country Status (8)

Country Link
EP (1) EP2509534A1 (fr)
JP (5) JP5833563B2 (fr)
KR (1) KR101685431B1 (fr)
CN (1) CN102724930B (fr)
AU (1) AU2010328077B2 (fr)
BR (1) BR112012013556A2 (fr)
CA (1) CA2777160C (fr)
WO (1) WO2011072148A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11116618B2 (en) 2009-11-23 2021-09-14 Boston Scientific Scimed, Inc. Patterned sling implant and method

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013008254A2 (pt) 2010-10-06 2017-12-12 Ams Res Corp implante configurado para inserção transvaginal em um paciente do sexo feminino para tratar um distúrbio pélvico, e, método para implantar cirurgicamente uma malha em um paciente do sexo feminino
US9949811B2 (en) 2011-02-23 2018-04-24 Boston Scientific Scimed, Inc. Pelvic implant and therapeutic agent system and method
US10034735B2 (en) 2011-03-28 2018-07-31 Boston Scientific Scimed, Inc. Implants, tools, and methods for treatments of pelvic conditions
WO2012135710A1 (fr) 2011-03-30 2012-10-04 Ams Research Corporation Implants, outils et procédés pour le traitement d'états pelviens pathologiques
WO2013009834A1 (fr) 2011-07-11 2013-01-17 Ams Research Corporation Implants, outils, et méthodes de traitement des affections pelviennes
WO2013020076A1 (fr) 2011-08-03 2013-02-07 Ams Research Corporation Systèmes, méthodes et implants dans le traitement du prolapsus ou de l'incontinence
FR2985171B1 (fr) * 2011-12-29 2014-06-06 Sofradim Production Prothese pour hernie avec moyen de marquage
WO2013146220A1 (fr) 2012-03-30 2013-10-03 テルモ株式会社 Instrument de perforation et dispositif de perforation
US9649114B2 (en) 2012-07-24 2017-05-16 Ams Research Corporation Systems, tools, and methods for connecting to tissue
WO2014055521A1 (fr) 2012-10-01 2014-04-10 Ams Research Corporation Implant conducteur et dégradable destiné au traitement des tissus pelviens
CA2905345A1 (fr) 2013-03-15 2014-09-25 Ams Research Corporation Systemes, outils et procedes pour raccorder un tissu
WO2019055311A1 (fr) * 2017-09-12 2019-03-21 W. L. Gore & Associates, Inc. Substrat doté d'entretoises rotatives pour dispositif médical

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011063412A2 (fr) * 2009-11-23 2011-05-26 Ams Research Corporation Implant à motifs et procédé

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6382214B1 (en) 1998-04-24 2002-05-07 American Medical Systems, Inc. Methods and apparatus for correction of urinary and gynecological pathologies including treatment of male incontinence and female cystocele
US7025063B2 (en) 2000-09-07 2006-04-11 Ams Research Corporation Coated sling material
US20060205995A1 (en) * 2000-10-12 2006-09-14 Gyne Ideas Limited Apparatus and method for treating female urinary incontinence
US20020147382A1 (en) 2001-01-23 2002-10-10 Neisz Johann J. Surgical articles and methods
US6612977B2 (en) 2001-01-23 2003-09-02 American Medical Systems Inc. Sling delivery system and method of use
US6641525B2 (en) 2001-01-23 2003-11-04 Ams Research Corporation Sling assembly with secure and convenient attachment
US7407480B2 (en) 2001-07-27 2008-08-05 Ams Research Corporation Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele
US6648921B2 (en) 2001-10-03 2003-11-18 Ams Research Corporation Implantable article
US7766926B2 (en) * 2002-04-30 2010-08-03 Vance Products Incorporated Sling for supporting tissue
WO2004017845A1 (fr) * 2002-08-23 2004-03-04 Kvinno Centre Pty Ltd Dispositif d'ancrage et sa mise en oeuvre
US7303525B2 (en) 2003-08-22 2007-12-04 Ams Research Corporation Surgical article and methods for treating female urinary incontinence
US7347812B2 (en) 2003-09-22 2008-03-25 Ams Research Corporation Prolapse repair
US20050234291A1 (en) * 2004-03-30 2005-10-20 Peter Gingras Medical device
US7351197B2 (en) 2004-05-07 2008-04-01 Ams Research Corporation Method and apparatus for cystocele repair
US7500945B2 (en) 2004-04-30 2009-03-10 Ams Research Corporation Method and apparatus for treating pelvic organ prolapse
CA2596360C (fr) * 2005-02-04 2015-04-07 Ams Research Corporation Implants chirurgicaux, methodes associees et systemes
WO2007070141A1 (fr) * 2005-09-12 2007-06-21 Proxy Biomedical Limited Implants de partie molle et procede de fabrication
ES2470338T3 (es) * 2005-11-14 2014-06-23 C.R. Bard, Inc. Sistema de anclaje de eslinga
CA2641789C (fr) 2006-02-16 2015-12-22 Ams Research Corporation Articles chirurgicaux et methodes pour traiter des affections pelviennes
BRPI0712370A2 (pt) * 2006-06-22 2012-06-12 Ams Res Corp sistema e mÉtodo para prover suporte para tecido corporal para abrandar incontinÊncia
EP3045120A1 (fr) 2006-10-26 2016-07-20 AMS Research Corporation Articles chirurgicaux de traitement des conditions pelviennes
US9427296B2 (en) * 2007-06-12 2016-08-30 Promedon S.A. Micro sling and implantation tool for urinary incontinence and faecal incontinence treatment
WO2009017680A2 (fr) 2007-07-27 2009-02-05 Ams Research Corporation Traitements du plancher pelvien et outils et implants associés
US20090149700A1 (en) * 2007-11-02 2009-06-11 Ruben Garcia Method and apparatus for pubic sling insertion
CN101396292B (zh) * 2008-08-27 2012-02-22 广东冠昊生物科技股份有限公司 一体化尿道吊带

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011063412A2 (fr) * 2009-11-23 2011-05-26 Ams Research Corporation Implant à motifs et procédé

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2011072148A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11116618B2 (en) 2009-11-23 2021-09-14 Boston Scientific Scimed, Inc. Patterned sling implant and method

Also Published As

Publication number Publication date
CA2777160A1 (fr) 2011-06-16
KR101685431B1 (ko) 2016-12-12
KR20120098835A (ko) 2012-09-05
AU2010328077B2 (en) 2013-07-11
BR112012013556A2 (pt) 2017-07-04
CN102724930A (zh) 2012-10-10
CN102724930B (zh) 2015-08-26
CA2777160C (fr) 2018-04-24
AU2010328077A1 (en) 2012-05-17
JP6584536B2 (ja) 2019-10-02
JP2013513441A (ja) 2013-04-22
JP6584535B2 (ja) 2019-10-02
JP2015221213A (ja) 2015-12-10
JP6077593B2 (ja) 2017-02-08
JP2018075433A (ja) 2018-05-17
JP2018075434A (ja) 2018-05-17
JP2017060893A (ja) 2017-03-30
JP5833563B2 (ja) 2015-12-16
WO2011072148A1 (fr) 2011-06-16
WO2011072148A4 (fr) 2011-07-07
WO2011072148A8 (fr) 2011-08-18

Similar Documents

Publication Publication Date Title
US11116618B2 (en) Patterned sling implant and method
CA2777160C (fr) Implant en echarpe a motifs
US10028817B2 (en) Patterned implant and method
AU2013221965B2 (en) Patterned sling implant and method
AU2015201164B2 (en) Patterned implant and method
AU2016231484B2 (en) Patterned implant and method
AU2013206296B2 (en) Patterned implant and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120515

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1171359

Country of ref document: HK

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ASTORA WOMEN'S HEALTH, LLC

17Q First examination report despatched

Effective date: 20171102

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BOSTON SCIENTIFIC SCIMED, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190702